Patents by Inventor Susanne Schmaus

Susanne Schmaus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage of oligonucleotides suitable for the treatment of tumors
    Patent number: 8822425
    Abstract: A method for preventing and/or treating a tumor, the method comprising: intravenously administering an antisense oligonucleotide in an amount of between about 400 to about 800 mg/m2/treatment cycle, the antisense oligonucleotide comprises 8 to 30 nucleotide building blocks, which hybridizes with mRNA of TGF-beta-2, -1 and/or -3 for the preparation of a pharmaceutical composition.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: September 2, 2014
    Assignee: Antisense Pharma GmbH
    Inventors: Karl-Hermann Schlingensiepen, Hubert Heinrichs, Susanne Schmaus
  • Dosage of oligonucleotides suitable for the treatment of tumors
    Publication number: 20100286236
    Abstract: A method for preventing and/or treating a tumor, the method comprising: intravenously administering an antisense oligonucleotide in an amount of between about 400 to about 800 mg/m2/treatment cycle, the antisense oligonucleotide comprises 8 to 30 nucleotide building blocks, which hybridizes with mRNA of TGF-beta-2, -1 and/or -3 for the preparation of a pharmaceutical composition.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 11, 2010
    Inventors: Karl-Hermann Schlingensiepen, Hubert Heinrichs, Susanne Schmaus